These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 12661474)
21. No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment. Takahashi H; Yoshida K; Ito K; Sato K; Kamata M; Higuchi H; Shimizu T; Ito K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K Eur Neuropsychopharmacol; 2002 Oct; 12(5):477-81. PubMed ID: 12208565 [TBL] [Abstract][Full Text] [Related]
22. Electrocardiographic findings during extended clinical trials of fluvoxamine in depression: one years experience. Hochberg HM; Kanter D; Houser VP Pharmacopsychiatry; 1995 Nov; 28(6):253-6. PubMed ID: 8773292 [TBL] [Abstract][Full Text] [Related]
24. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044 [TBL] [Abstract][Full Text] [Related]
25. Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Mauri MC; Ferrara A; Boscati L; Bravin S; Zamberlan F; Alecci M; Invernizzi G Neuropsychobiology; 1998; 37(3):124-9. PubMed ID: 9597668 [TBL] [Abstract][Full Text] [Related]
26. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy. Miljković BR; Pokrajac M; Timotijević I; Varagić V Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381 [TBL] [Abstract][Full Text] [Related]
27. [Fluvoxamine (fevarin) in psychogenic depression]. Dubnitskaia EB Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(12):48-50. PubMed ID: 11811127 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and pharmacokinetics of fluvoxamine maleate in patients with mild depression undergoing hemodialysis. Kamo T; Horikawa N; Tsuruta Y; Miyasita M; Hatakeyama H; Maebashi Y Psychiatry Clin Neurosci; 2004 Apr; 58(2):133-7. PubMed ID: 15009816 [TBL] [Abstract][Full Text] [Related]
29. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275 [TBL] [Abstract][Full Text] [Related]
31. [A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine]. Lopukhov IG Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(4):53-7. PubMed ID: 9214192 [TBL] [Abstract][Full Text] [Related]
32. [Fluvoxamine (fevarin) in the treatment of depression]. Sheĭfer MS; Tsybina MI; Davydenko MV Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):64-7. PubMed ID: 11195542 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study. Fukuchi T; Kanemoto K Int Clin Psychopharmacol; 2002 Mar; 17(2):53-8. PubMed ID: 11890186 [TBL] [Abstract][Full Text] [Related]
34. Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study. Asakura S; Tajima O; Koyama T Int J Neuropsychopharmacol; 2007 Apr; 10(2):263-74. PubMed ID: 16573847 [TBL] [Abstract][Full Text] [Related]
35. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Smeraldi E; Zanardi R; Benedetti F; Di Bella D; Perez J; Catalano M Mol Psychiatry; 1998 Nov; 3(6):508-11. PubMed ID: 9857976 [TBL] [Abstract][Full Text] [Related]
36. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression. Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464 [TBL] [Abstract][Full Text] [Related]
37. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder. Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433 [TBL] [Abstract][Full Text] [Related]
38. Patterns of symptom improvement during antidepressant treatment of delusional depression. Serretti A; Lattuada E; Zanardi R; Franchini L; Smeraldi E Psychiatry Res; 2000 May; 94(2):185-90. PubMed ID: 10808044 [TBL] [Abstract][Full Text] [Related]
39. Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction. Kito S; Koga Y Int Psychogeriatr; 2006 Dec; 18(4):749-51. PubMed ID: 17026779 [No Abstract] [Full Text] [Related]
40. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. Franchini L; Serretti A; Gasperini M; Smeraldi E J Psychiatr Res; 1998; 32(5):255-9. PubMed ID: 9789202 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]